Widdington, United Kingdom

Véronique Birault


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Véronique Birault

Introduction

Véronique Birault is a notable inventor based in Widdington, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obesity and related disorders. His work has led to the development of novel compounds that hold promise for medical applications.

Latest Patents

Véronique Birault holds a patent for "Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity." This invention involves the use of a compound comprising formula (I), or a salt, ester, amide, or prodrug thereof, in the treatment of obesity and related disorders. The invention also relates to novel compounds within formula (I), processes for preparing them, and pharmaceutical compositions containing them. In formula (I), A is an optionally substituted thienyl moiety, Y is O, S, or NR, R is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl, or a substituted derivative of any of the foregoing groups, and R is hydrogen or a group as defined for R. This patent highlights his innovative approach to addressing significant health issues.

Career Highlights

Véronique Birault has been associated with Alizyme Therapeutics Limited, where he has contributed to various research initiatives. His work has focused on developing therapeutic solutions that can improve health outcomes for individuals struggling with obesity. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Véronique has collaborated with notable colleagues such as Harold Francis Hodson and Christopher Robert Dunk. These collaborations have fostered an environment of innovation and have led to advancements in their shared research interests.

Conclusion

Véronique Birault's contributions to the field of pharmaceuticals, particularly through his patent on Thieno-(1,3)-oxazin-4-ones, demonstrate his commitment to innovation and improving health outcomes. His work continues to

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…